Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director | November 05, 2025 | November 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date November 05, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.80 · Expires 2035-11-05 | Direct | 13,790 |
Reported balance
After 2025-11-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-05 · Grant · Acquired 13,790 · Balance 13,790 F1: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 05, 2025 Filed Nov 7, 2025 17:14 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 13,790 | $6.80 Strike: $6.80 | $93,772.00 |
DisclosureSEC source: 0001628280-25-050522 · wk-form4_1762535675.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,790 Underlying: Common Stock · 13,790 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| March 25, 2025 Filed Apr 2, 2025 20:20 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | OtherCommon Stock | 4,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016197 · wk-form4_1743625230.xml · nonDerivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,717 F1 · kind: Shares were transferred to a donor-advised charitable trust fund; upon receipt of the shares, the fund sold the shares. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 17:14 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 18,715 | $4.64 Strike: $4.64 | $86,837.60 |
DisclosureSEC source: 0001628280-24-048217 · wk-form4_1731950043.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,715 Underlying: Common Stock · 18,715 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:57 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 15,495 | $5.51 Strike: $5.51 | $85,377.45 |
DisclosureSEC source: 0001628280-23-037245 · wk-form4_1699376211.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,495 Underlying: Common Stock · 15,495 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| November 01, 2022 Filed Aug 17, 2023 16:09 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 11,480 | $7.00 Strike: $7.00 | $80,360.00 |
DisclosureSEC source: 0001628280-23-029778 · wf-form4_169228853672738.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,480 Underlying: Common Stock · 11,480 shares Expires 2032-11-01 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1,2023, respectively. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 18:25 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 8,333 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001628280-22-026398 · wf-form4_166577191015059.xml · derivative · entry 3 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2022-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018 Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 18:25 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Tax withholdingCommon Stock | 3,562 | $7.51 | $26,750.62 |
DisclosureSEC source: 0001628280-22-026398 · wf-form4_166577191015059.xml · nonDerivative · entry 2 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,638 F1 · kind: Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 18:25 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 8,333 | $3.21 | $26,748.93 |
DisclosureSEC source: 0001628280-22-026398 · wf-form4_166577191015059.xml · nonDerivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:31 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 8,045 | $10.10 Strike: $10.10 | $81,254.50 |
DisclosureSEC source: 0001628280-21-022605 · wf-form4_163649706826161.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,045 Underlying: Common Stock · 8,045 shares Expires 2031-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5,2022, respectively. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 19:27 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 4,167 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001628280-21-005610 · wf-form4_161670040991722.xml · derivative · entry 3 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2021-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest and are exercisable over a four month period, with vesting to occur on May 1, 2016 and August 1, 2016, respectively. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 19:27 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Tax withholdingCommon Stock | 1,340 | $11.35 | $15,209.00 |
DisclosureSEC source: 0001628280-21-005610 · wf-form4_161670040991722.xml · nonDerivative · entry 2 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,827 F1 · kind: Represents a "net exercise" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on March 23, 2021. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 19:27 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 4,167 | $3.65 | $15,209.55 |
DisclosureSEC source: 0001628280-21-005610 · wf-form4_161670040991722.xml · nonDerivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 14:29 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | SaleCommon Stock | 31,443 | $11.35 | $356,975.52 |
DisclosureSEC source: 0001628280-20-017581 · wf-form4_160821535638533.xml · nonDerivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:59 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 8,333 | $11.96 Strike: $11.96 | $99,662.68 |
DisclosureSEC source: 0001628280-20-017364 · wf-form4_160763754086190.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2025-12-08 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on December 8, 2020, March 8, 2021, June 8, 2021 and September 8, 2021, respectively. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:16 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 8,333 | $5.43 Strike: $5.43 | $45,248.19 |
DisclosureSEC source: 0001628280-19-013531 · wf-form4_157307856664600.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2024-11-03 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 16:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 8,333 | $12.73 Strike: $12.73 | $106,079.09 |
DisclosureSEC source: 0001628280-18-013559 · wf-form4_154143624704516.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2023-11-01 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2018, February 1, 2019, May 1, 2019 and August 1, 2019, respectively. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:12 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 8,333 | $3.21 Strike: $3.21 | $26,748.93 |
DisclosureSEC source: 0001628280-17-011463 · wf-form4_151060751099362.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2022-10-31 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 1, 2018, May 1, 2018 and August 1, 2018, respectively. Read SEC document |
| January 03, 2017 Filed Mar 10, 2017 16:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 45,000 | $2.85 Strike: $1.59 | $128,250.00 |
DisclosureSEC source: 0001628280-17-002464 · wf-form4_148916179808463.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2021-11-01 F1 · derivative.exercise_date: The Options will vest over a three-year period: upon completion of one full year of service, 1/3rd of the Option will be fully vested; upon completion of two full years of service, 2/3rds of the Option will be fully vested; upon completion of three full years of service, 100% of the Option will be fully vested. Read SEC document |
| November 01, 2016 Filed Nov 16, 2016 14:01 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 8,333 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001628280-16-021508 · wf-form4_147930488420451.xml · derivative · entry 1 Breitfeld Philip P. · CIK 0001690133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2021-11-01 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.